364 related articles for article (PubMed ID: 23845456)
1. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
[TBL] [Abstract][Full Text] [Related]
2. The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
Zhou Y; Xu X; Lv H; Wen Q; Li J; Tan L; Li J; Sheng X
PLoS One; 2016; 11(5):e0155250. PubMed ID: 27227769
[TBL] [Abstract][Full Text] [Related]
3. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
Huang S; Liao Q; Li W; Deng G; Jia M; Fang Q; Ji H; Meng M
Bull Cancer; 2021 Apr; 108(4):359-368. PubMed ID: 33743960
[TBL] [Abstract][Full Text] [Related]
4. USP54 is a potential therapeutic target in castration-resistant prostate cancer.
Zhou C; Zhang X; Ma H; Zhou Y; Meng Y; Chen C; Shi G; Yu W; Zhang J
BMC Urol; 2024 Feb; 24(1):32. PubMed ID: 38321455
[TBL] [Abstract][Full Text] [Related]
5. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
Zou P; Chen Z; He Q; Zhuo Y
Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of molecular subtypes identification based on anoikis-related lncRNAs in castration-resistant prostate cancer.
Chen K; Zhang Y; Li C; Liu Y; Cao Q; Zhang X
Cell Signal; 2024 May; 117():111104. PubMed ID: 38373667
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
[TBL] [Abstract][Full Text] [Related]
8. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
Yadav A; Biswas T; Praveen A; Ganguly P; Bhattacharyya A; Verma A; Datta D; Ateeq B
Cancer Res Commun; 2023 Oct; 3(10):2044-2061. PubMed ID: 37812088
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.
Sato R; Yamasaki M; Hirai K; Matsubara T; Nomura T; Sato F; Mimata H
Oncol Rep; 2015 Jan; 33(1):58-66. PubMed ID: 25370833
[TBL] [Abstract][Full Text] [Related]
10. HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1.
You H; Song G; Xu Z; Chen S; Shen W; Liu H; Deng B; Li J; Huang G
J Transl Med; 2024 Feb; 22(1):178. PubMed ID: 38369471
[TBL] [Abstract][Full Text] [Related]
11. JNK promotes the progression of castration-resistant prostate cancer.
Feng Y; Cao H; Wang D; Chen L; Gao R; Sun P
Acta Biochim Pol; 2023 Dec; 70(4):817-822. PubMed ID: 38099475
[TBL] [Abstract][Full Text] [Related]
12. The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence.
Smith T; White T; Chen Z; Stewart LV
Exp Cell Res; 2024 Apr; 437(1):113991. PubMed ID: 38462208
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.
Xu D; Wang W; Wang D; Ding J; Zhou Y; Zhang W
Noncoding RNA Res; 2024 Jun; 9(2):388-406. PubMed ID: 38511067
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.
Han Q; Xie QR; Li F; Cheng Y; Wu T; Zhang Y; Lu X; Wong AST; Sha J; Xia W
Theranostics; 2021; 11(13):6526-6541. PubMed ID: 33995674
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes in breast cancer cells.
Zeng L; Cen Y; Chen J
Oncol Lett; 2018 Feb; 15(2):2117-2122. PubMed ID: 29434914
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer.
Xin R; Hu B; Qu D; Chen D
Pulm Pharmacol Ther; 2023 Jan; ():102199. PubMed ID: 36690318
[TBL] [Abstract][Full Text] [Related]
17. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in Prostate Cancer Growth and Metastasis.
Xiao C; Liang W
Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
[TBL] [Abstract][Full Text] [Related]
18. A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX.
Zhong J; Liu D; Yang Q; Ding J; Chen X
Drug Des Devel Ther; 2024; 18():859-870. PubMed ID: 38524880
[TBL] [Abstract][Full Text] [Related]
19. MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.
Hussein MA; Valinezhad K; Adel E; Munirathinam G
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201661
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer.
Rinella L; Fiorentino G; Compagno M; Grange C; Cedrino M; Marano F; Bosco O; Vissio E; Delsedime L; D'Amelio P; Bussolati B; Arvat E; Catalano MG
Cancer Gene Ther; 2024 May; ():. PubMed ID: 38740881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
